National Kidney Foundation features DaVita Clinical Research Results at 2018 Spring Clinical Meetings

MINNEAPOLIS, April 9, 2018

The Spring Clinical Meeting convenes roughly 3,000 health care professionals to learn about the newest developments in nephrology practice and present research findings.

"Sharing research and exchanging ideas at this conference helps the entire kidney care community evolve and understand how we can deliver even better patient care," said Steven Brunelli, M.D., MSCE, vice president and medical director of health analytics for DCR.

Researchers from DCR and DaVita Kidney Care will present results from several retrospective studies. The data originates from DCR and its independent research partners in the academic, pharmaceutical and biotech research communities.

DCR poster titles include:

• Pharmacokinetics, Safety, and Tolerability of Thrice-Weekly Dosing of Cinacalcet in Hemodialysis Patients with Secondary Hyperparathyroidism
• Hospitalizations among Peritoneal Dialysis and Home Hemodialysis Patients with Symptoms of Depression
• Characterization of End-Stage Renal Disease Patients on the Transplant Waitlist

To learn more about DCR, visit www.DaVitaClinicalResearch.com.

About DaVita Clinical Research
DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita Inc., uses its extensive, applied database and real-world healthcare experience to assist pharmaceutical and medical device companies in the design, recruitment and completion of retrospective, prospective and pragmatic clinical trials.  DCR's Late Phase Clinical Research (Phase IIb through post-marketing) network of physicians and investigative sites are focused on providing world-class research in both complex/specialty populations and therapeutic areas and especially in CKD and ESRD populations. To learn more about DCR, visit DaVitaClinicalResearch.com.